{"transactions":[{"id":3530066,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":140825,"kind":"person","name":"LAMOND PIERRE","position":1,"cik":"0001190683","reported_name":"LAMOND PIERRE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157679,"kind":"person","name":"Lamond Christine","position":2,"cik":"0001775830","reported_name":"Lamond Christine","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2019-05-13T19:50:02.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":462028,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Pierre R. Lamond is the trustee of the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":462028},"source":{"system":"sec-edgar","filing":"0001209191-19-029477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1775830/000120919119029477/doc4.xml","form_type":"4"}},{"id":3530065,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":140825,"kind":"person","name":"LAMOND PIERRE","position":1,"cik":"0001190683","reported_name":"LAMOND PIERRE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157679,"kind":"person","name":"Lamond Christine","position":2,"cik":"0001775830","reported_name":"Lamond Christine","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Redeemable Convertible Preferred Stock","published_at":"2019-05-13T19:50:02.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":462027,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Christine E. Lamond is the trustee of the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":462027},"source":{"system":"sec-edgar","filing":"0001209191-19-029477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1775830/000120919119029477/doc4.xml","form_type":"4"}},{"id":3530064,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":140825,"kind":"person","name":"LAMOND PIERRE","position":1,"cik":"0001190683","reported_name":"LAMOND PIERRE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157679,"kind":"person","name":"Lamond Christine","position":2,"cik":"0001775830","reported_name":"Lamond Christine","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Redeemable  Convertible Preferred Stock","published_at":"2019-05-13T19:50:02.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":961510,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pierre R. and Christine E. Lamond Trust 11-22-85"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pierre R. Lamond is the trustee of the Pierre R. and Christine E. Lamond Trust 11-22-85, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. and Christine E. Lamond Trust 11-22-85."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":961510},"source":{"system":"sec-edgar","filing":"0001209191-19-029477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1775830/000120919119029477/doc4.xml","form_type":"4"}},{"id":3530063,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":140825,"kind":"person","name":"LAMOND PIERRE","position":1,"cik":"0001190683","reported_name":"LAMOND PIERRE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157679,"kind":"person","name":"Lamond Christine","position":2,"cik":"0001775830","reported_name":"Lamond Christine","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Redeemable Convertible Preferred Stock","published_at":"2019-05-13T19:50:02.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":500482,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Pierre R. Lamond is the trustee of the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":500482},"source":{"system":"sec-edgar","filing":"0001209191-19-029477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1775830/000120919119029477/doc4.xml","form_type":"4"}},{"id":3530062,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":140825,"kind":"person","name":"LAMOND PIERRE","position":1,"cik":"0001190683","reported_name":"LAMOND PIERRE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157679,"kind":"person","name":"Lamond Christine","position":2,"cik":"0001775830","reported_name":"Lamond Christine","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Redeemable Convertible Preferred Stock","published_at":"2019-05-13T19:50:02.000Z","date":"2019-05-13","kind":"exercise","acquired":false,"shares":500483,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Christine E. Lamond is the trustee of the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":500483},"source":{"system":"sec-edgar","filing":"0001209191-19-029477","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1775830/000120919119029477/doc4.xml","form_type":"4"}},{"id":3530061,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":140825,"kind":"person","name":"LAMOND PIERRE","position":1,"cik":"0001190683","reported_name":"LAMOND PIERRE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157679,"kind":"person","name":"Lamond Christine","position":2,"cik":"0001775830","reported_name":"Lamond Christine","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T19:50:02.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":961510,"ownership":{"direct":false,"nature":"By Pierre R. and Christine E. Lamond Trust 11-22-85"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Pierre R. Lamond is the trustee of the Pierre R. and Christine E. Lamond Trust 11-22-85, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. and Christine E. Lamond Trust 11-22-85."}],"balance_after":961510,"source":{"system":"sec-edgar","filing":"0001209191-19-029477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1775830/000120919119029477/doc4.xml","form_type":"4"}},{"id":3530060,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":140825,"kind":"person","name":"LAMOND PIERRE","position":1,"cik":"0001190683","reported_name":"LAMOND PIERRE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157679,"kind":"person","name":"Lamond Christine","position":2,"cik":"0001775830","reported_name":"Lamond Christine","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T19:50:02.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":962510,"ownership":{"direct":false,"nature":"By Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Pierre R. Lamond is the trustee of the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Pierre R. Lamond 2019 Annuity Trust A dated March 4, 2019."}],"balance_after":962510,"source":{"system":"sec-edgar","filing":"0001209191-19-029477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1775830/000120919119029477/doc4.xml","form_type":"4"}},{"id":3530059,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":140825,"kind":"person","name":"LAMOND PIERRE","position":1,"cik":"0001190683","reported_name":"LAMOND PIERRE","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":157679,"kind":"person","name":"Lamond Christine","position":2,"cik":"0001775830","reported_name":"Lamond Christine","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-13T19:50:02.000Z","date":"2019-05-13","kind":"exercise","acquired":true,"shares":962510,"ownership":{"direct":false,"nature":"By Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The total represents shares received upon conversion of shares of Series A Redeemable Convertible Preferred Stock and shares of Series B Redeemable Convertible Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A Redeemable Convertible Preferred Stock and each share of Series B Redeemable Convertible Preferred Stock automatically converted into one share of Issuer's Common Stock, respectively, for no additional consideration at the completion of the Issuer's initial public offering. The Redeemable Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Christine E. Lamond is the trustee of the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019, and has sole voting and dispositive power with respect to the shares held of record by the Christine E. Lamond 2019 Annuity Trust A dated March 4, 2019."}],"balance_after":962510,"source":{"system":"sec-edgar","filing":"0001209191-19-029477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1775830/000120919119029477/doc4.xml","form_type":"4"}}]}